Here, we evaluate the TMPRSS2-ERG fusion gene in prostate cancer tissue, as representative of a translocation-positive epithelial tumor, for a putative application as a noninvasive ctDNA biomarker. The gene discussed is ERG; the disease is prostate carcinoma.